Catabasis Pharmaceuticals Inc buy melinda
Start price
10.07.16
/
50%
€196.46
Target price
04.08.16
€270.60
Performance (%)
39.97%
End price
04.08.16
€274.98
Summary
This prediction ended on 04.08.16 with a price of €274.98. The BUY prediction by melinda for Catabasis Pharmaceuticals Inc saw massive gains of 39.97%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Catabasis Pharmaceuticals Inc | - | - | - | - |
iShares Core DAX® | 0.393% | -2.618% | 11.310% | 10.727% |
iShares Nasdaq 100 | 0.394% | -10.309% | 23.697% | 33.228% |
iShares Nikkei 225® | 1.038% | -8.365% | 7.878% | 1.931% |
iShares S&P 500 | -0.046% | -4.991% | 21.704% | 34.810% |
Comments by melinda for this prediction
In the thread Catabasis Pharmaceuticals Inc diskutieren
(Zielkurs erreicht)
Stopped prediction by melinda for Catabasis Pharmaceuticals Inc
Catabasis Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€8.84
27.10.20
27.10.20
€15.00
04.11.21
04.11.21
-20.00%
05.11.21
05.11.21
Catabasis Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€29.28
03.03.20
03.03.20
€33.00
27.10.20
27.10.20
-69.82%
27.10.20
27.10.20
Catabasis Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€188.33
04.10.17
04.10.17
€270.60
19.12.17
19.12.17
-53.02%
19.12.17
19.12.17
Catabasis Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€67.65
02.02.17
02.02.17
€108.24
10.03.17
10.03.17
68.84%
10.03.17
10.03.17
Catabasis Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€188.34
16.12.16
16.12.16
€216.48
22.12.16
22.12.16
18.10%
22.12.16
22.12.16